what are the Recommendations for Cardio-Oncology?
In patients with cardiovascular risk factors or known cardiac disease receiving potentially cardiotoxic anticancer therapies, monitoring of cardiac function is reasonable for the early iden- tification of drug-induced cardiomyopathy.